Real-time insights. Smarter decisions. Better trades.
🔍 Search Stocks 14 day Free Trial
SONIC HEALTHCARE LIMITED (SHL)ASX AI Signals has generated 2 signal(s) for SHL during the last 90 days, indicating Moderate trading activity
Latest SHL Signals | |
| 06/05/2026 | SELL |
| 08/04/2026 | SELL |
| 09/03/2026 | BUY |
SHL Share Price | |
| Current Price | $21.250 |
| 52 Week High | $27.627 |
| 52 Week Low: | $18.390 |
| Trading at (% of 52 Week High) | 76.92% |
Sonic Healthcare Limited (ASX: SHL) is a global medical diagnostics company that provides laboratory and pathology services. The company operates a network of laboratories offering testing and diagnostic services to healthcare providers, hospitals, and patients. Sonic Healthcare serves markets in Australia, the United States, Europe, and New Zealand.
The Health Care Equipment & Services sector on the ASX includes companies that produce medical devices, equipment, and supplies, as well as those providing healthcare-related services. This sector covers a wide range of products such as surgical instruments, diagnostic machines, and health monitoring devices. It also includes businesses involved in healthcare management, medical laboratories, and support services. These companies play a key role in supporting hospitals, clinics, and other healthcare providers to improve patient care. The sector is influenced by factors like technological advances, regulatory changes, and demand for healthcare services.
The SELL recommendation for SONIC HEALTHCARE LIMITED (SHL) is supported by moderate bearish signals, but the confidence is tempered by the company's stable market position and consistent earnings. Caution is advised due to potential sector volatility and external economic factors.
Sonic becomes the first committed commercial laboratory partner in CellCarta's single-site PMA CDx bridging strategy, supporting oncology, autoimmune and other precision medicine programs.
MONTREAL, May 27, 2026 /PRNewswire/ -- CellCarta, a leading global CRO laboratory to the biopharmaceutical ind For many, the main point of investing is to generate higher returns than the overall market. But even the best stock picker will only win with some selections. At this point some shareholders may be questioning their investment in Sonic Healthcare Limited (ASX:SHL), since the last five years saw the Key Insights
The considerable ownership by individual investors in Sonic Healthcare indicates that they collectively have a greater say in management and business strategy A total of 25 investors have a majority stake in the company with 46% ownership Insiders have bought recently
AI is about to c Sonic Healthcare Limited (ASX:SHL) is about to trade ex-dividend in the next four days. The ex-dividend date generally occurs two days before the record date, which is the day on which shareholders need to be on the company's books in order to receive a dividend. The ex-dividend date is an important Sonic Healthcare Ltd. Sponsored ADR (SKHHY) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.
The sole determinanLatest SONIC HEALTHCARE LIMITED(SHL) News
CellCarta and Sonic Healthcare Establish Strategic Partnership to Commercialize Companion Diagnostics Through Lab Network
Sonic Healthcare (ASX:SHL) earnings and shareholder returns have been trending downwards for the last five years, but the stock lifts 7.4% this past week
Painful week for individual investors invested in Sonic Healthcare Limited (ASX:SHL) after 4.2% drop, institutions also suffered losses
Do These 3 Checks Before Buying Sonic Healthcare Limited (ASX:SHL) For Its Upcoming Dividend
All You Need to Know About Sonic Healthcare Ltd. Sponsored ADR (SKHHY) Rating Upgrade to Buy
Get access to daily BUY & SELL signals, advanced AI analysis, watchlists and email alerts.
14 Day Free Trial • Cancel Anytime • Founders Price $15/month
Start My Free Trial